首页> International journal of radiation oncology, biology, physics> Simultaneous Focal Boost With Stereotactic Radiation Therapy for Localized Intermediate- to High-Risk Prostate Cancer: Primary Outcomes of the SPARC Phase 2 Trial.

Simultaneous Focal Boost With Stereotactic Radiation Therapy for Localized Intermediate- to High-Risk Prostate Cancer: Primary Outcomes of the SPARC Phase 2 Trial.

导出原文传递

翻译打印收藏纠错

第一作者： Binnaz,Yasar

第一单位： Royal Marsden NHS Foundation Trust, London, United Kingdom; Institute of Cancer Research, London, United Kingdom. Electronic address: binnaz.yasar@rmh.nhs.uk.

作者： Binnaz,Yasar ^[1] ; Yae-Eun,Suh ^[2] ; Ewan,Chapman ^[3] ; Luke,Nicholls ^[4] ; Daniel,Henderson ^[5] ; Caroline,Jones ^[6] ; Kirsty,Morrison ^[7] ; Emma,Wells ^[2] ; Julia,Henderson ^[2] ; Carole,Meehan ^[2] ; Aslam,Sohaib ^[2] ; Helen,Taylor ^[2] ; Alison,Tree ^[8] ; Nicholas,van As ^[8]

作者单位： Royal Marsden NHS Foundation Trust, London, United Kingdom; Institute of Cancer Research, London, United Kingdom. Electronic address: binnaz.yasar@rmh.nhs.uk. ^[1] Royal Marsden NHS Foundation Trust, London, United Kingdom. ^[2] St Bartholomew's Hospital, London, United Kingdom. ^[3] Princess Alexandra Hospital, Brisbane, Australia. ^[4] University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom. ^[5] Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom. ^[6] Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom. ^[7] Royal Marsden NHS Foundation Trust, London, United Kingdom; Institute of Cancer Research, London, United Kingdom. ^[8]